Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2619 |  DSGN Design Therapeutics, Inc. - Common Stock | 11.49 USD | -1.71% | -8.95% | -22.42% | +61.15% | 719.06 M USD | ||
| 2633 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 12.70 USD | +0.87% | -10.06% | -8.50% | +12.39% | 701.60 M USD | ||
| 2656 |  OLMA Olema Pharmaceuticals, Inc. - Common Stock | 7.82 USD | -1.51% | -6.79% | -23.33% | -4.52% | 684.23 M USD | ||
| 2657 |  WVE Wave Life Sciences Ltd. - Ordinary Shares | 3.47 USD | -1.98% | -10.80% | -27.10% | -51.54% | 683.76 M USD | ||
| 2667 |  AURA Aura Biosciences, Inc. - Common Stock | 6.51 USD | +0.77% | +6.55% | -8.82% | +7.43% | 675.12 M USD | ||
| 2669 |  MDXG MiMedx Group, Inc - Common Stock | 4.62 USD | +0.22% | -1.49% | -1.07% | -33.14% | 673.41 M USD | ||
| 2675 |  PHAR Pharming Group N.V. - ADS, each representing 10 | 9.53 USD | -1.24% | -4.22% | -12.65% | -34.86% | 668.70 M USD | ||
| 2676 |  IMMX Immix Biopharma, Inc. - Common Stock | 9.29 USD | -2.11% | -10.24% | -23.10% | +244.07% | 664.60 M USD | ||
| 2685 |  NVCT Nuvectis Pharma, Inc. - Common Stock | 20.13 USD | -0.79% | -4.64% | -9.69% | +236.62% | 655.87 M USD | ||
| 2688 |  ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.00 USD | -0.72% | +7.42% | -8.26% | +3.38% | 653.22 M USD | ||
| 2695 |  PRME Prime Medicine, Inc. - Common Stock | 3.58 USD | -8.21% | +16.99% | +6.23% | -42.99% | 649.33 M USD | ||
| 2708 |  IVA Inventiva S.A. - American Depository Shares | 3.32 USD | -1.48% | -7.00% | -24.72% | -31.55% | 641.55 M USD | ||
| 2723 |  CLYM Climb Bio, Inc. - Common Stock | 10.86 USD | +1.40% | -1.63% | -26.62% | +98.54% | 623.76 M USD | ||
| 2763 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 7.13 USD | +4.70% | -0.97% | -15.12% | -39.58% | 576.82 M USD | ||
| 2768 |  CRMD CorMedix Inc. - Common Stock | 7.32 USD | +0.55% | -0.68% | -9.85% | -35.22% | 570.55 M USD | ||
| 2773 |  STTK Shattuck Labs, Inc. - Common Stock | 5.66 USD | 0.00% | -19.37% | -8.86% | +152.68% | 568.06 M USD | ||
| 2774 |  DBVT DBV Technologies S.A. - American Depositary Shares | 9.55 USD | -2.25% | -12.55% | -29.31% | -38.43% | 565.48 M USD | ||
| 2778 |  MNPR Monopar Therapeutics Inc. - Common Stock | 83.98 USD | +0.24% | +7.21% | -24.03% | +53.75% | 563.69 M USD | ||
| 2794 |  SGMT Sagimet Biosciences Inc. - Series A Common Stock | 8.92 USD | +0.45% | -3.67% | -16.95% | +3.48% | 554.46 M USD | ||
| 2795 |  HELP Cybin Inc. - Common Stock | 10.72 USD | +2.00% | -11.55% | -21.75% | +19.51% | 553.49 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |